日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

碳酸酐酶 9 作为循环生物标志物和治疗靶点在接受阿特珠单抗联合贝伐珠单抗治疗的肝细胞癌患者中的应用

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013384
Sato, Yu; Kodama, Takahiro; Maesaka, Kazuki; Kai, Machiko; Murai, Kazuhiro; Tahata, Yuki; Saito, Yoshinobu; Nakabori, Tasuku; Ohkawa, Kazuyoshi; Tanaka, Satoshi; Sakamori, Ryotaro; Miyazaki, Masanori; Furuta, Kunimaro; Ishida, Hisashi; Matsumoto, Kengo; Tawara, Seiichi; Yakushijin, Takayuki; Nozaki, Yasutoshi; Hosui, Atsushi; Nishio, Akira; Tatsumi, Nobuyuki; Kakita, Naruyasu; Yoo, Changhoon; Fukai, Moto; Taketomi, Akinobu; Hikita, Hayato; Tatsumi, Tomohide; Takehara, Tetsuo
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma.

系统性免疫分析揭示了肝细胞癌联合免疫疗法反应的不同机制和预测性生物标志物。

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-013648
Nishio Akira, Kodama Takahiro, Daiku Kazuma, Maesaka Kazuki, Tanaka Satoshi, Nozaki Yasutoshi, Kurahashi Tomohide, Matsumoto Kengo, Nawa Takatoshi, Tawara Seiichi, Tokuda Yuki, Nakabori Tasuku, Sakamori Ryotaro, Ohkawa Kazuyoshi, Miyazaki Masanori, Yamamoto Shuhei, Shigeno Satoshi, Myojin Yuta, Tahata Yuki, Hikita Hayato, Takehara Tetsuo
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Impact of Prior Treatment History on Recurrence After Complete Response to Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

既往治疗史对不可切除肝细胞癌患者接受阿特珠单抗联合贝伐珠单抗治疗后完全缓解后复发的影响

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71552
Nakabori, Tasuku; Kawabata, Masaki; Mukai, Kaori; Hongyo, Hidenari; Maeda, Noboru; Urabe, Makiko; Kai, Yugo; Takada, Ryoji; Ikezawa, Kenji; Wada, Hiroshi; Gotoh, Kunihito; Ohkawa, Kazuyoshi
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden-High Unresectable Pancreatic Cancer and the Efficacy of Pembrolizumab Treatment

高肿瘤突变负荷不可切除胰腺癌患者的遗传和临床特征及帕博利珠单抗治疗的疗效

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.70492
Kai, Yugo; Ikezawa, Kenji; Kozumi, Kazuhiro; Urabe, Makiko; Takada, Ryoji; Kinomoto, Takumi; Masumoto, Takanori; Kawabata, Masaki; Kishimoto, Hiroki; Hosokawa, Kana; Mukai, Kaori; Nakabori, Tasuku; Yamaguchi, Yuko; Sugimoto, Naotoshi; Ohkawa, Kazuyoshi
胰腺癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Effects of Pancreatic Duct Stenting on Nutrition and Pancreatic Function in Unresectable Pancreatic Cancer: A Pilot Study

胰管支架置入术对不可切除胰腺癌患者营养和胰腺功能的影响：一项初步研究

期刊:JGH Open
影响因子:1.5
doi:10.1002/jgh3.70358
Watsuji, Ko; Ikezawa, Kenji; Kai, Yugo; Takada, Ryoji; Kawabata, Masaki; Kishimoto, Hiroki; Hosokawa, Kana; Seiki, Yusuke; Kozumi, Kazuhiro; Urabe, Makiko; Mukai, Kaori; Nakabori, Tasuku; Ohkawa, Kazuyoshi
胰腺癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Authors’ Response to Peer Reviews of “Assessing the Limitations of Large Language Models in Clinical Practice Guideline–Concordant Treatment Decision-Making on Real-World Data: Retrospective Study”

作者对“评估大型语言模型在基于真实世界数据的临床实践指南一致性治疗决策中的局限性：回顾性研究”一文的同行评审的回应

期刊:Annals of Vascular Diseases
影响因子:0.6
doi:10.3400/avd.cr.25-00096
Nakabori, Hiroki; Ueda, Hideyasu; Iino, Kenji; Roeschl, Tobias; Hoffmann, Marie; Hashemi, Djawid; Rarreck, Felix; Hinrichs, Nils; Trippel, Tobias Daniel; Gröschel, Matthias I; Unbehaun, Axel; Klein, Christoph; Kempfert, Jörg; Dreger, Henryk; O'Brien, Benjamin; Hindricks, Gerhard; Balzer, Felix; Falk, Volkmar; Meyer, Alexander
发表日期：2025
文献求助 收藏

Safety and Feasibility of Combining On-Demand Selective Locoregional Treatment with First-Line Atezolizumab Plus Bevacizumab for Patients with Unresectable Hepatocellular Carcinoma

对于不可切除的肝细胞癌患者，按需选择性局部区域治疗联合一线阿特珠单抗加贝伐珠单抗治疗的安全性和可行性

期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol31030117
Nakabori, Tasuku; Higashi, Sena; Abe, Yutaro; Mukai, Kaori; Ikawa, Toshiki; Konishi, Koji; Maeda, Noboru; Nakanishi, Katsuyuki; Hasegawa, Shinichiro; Wada, Hiroshi; Ohkawa, Kazuyoshi
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer

生殖系乳腺癌易感基因（gBRCA）检测及奥拉帕尼作为胰腺癌患者维持治疗的临床意义

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-024-12722-8
Kawamoto, Yasuharu; Yamai, Takuo; Ikezawa, Kenji; Seiki, Yusuke; Watsuji, Ko; Hirao, Takeru; Urabe, Makiko; Kai, Yugo; Takada, Ryoji; Mukai, Kaori; Nakabori, Tasuku; Uehara, Hiroyuki; Inoue, Tazuko; Fujisawa, Fumie; Ohkawa, Kazuyoshi
胰腺癌
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Giant iliac vein aneurysm secondary to traumatic arteriovenous fistula

外伤性动静脉瘘继发的巨大髂静脉瘤

期刊:
影响因子:
doi:10.1093/ehjimp/qyae126
Sakai, Ai; Ueda, Hideyasu; Nakabori, Hiroki; Iino, Kenji; Takemura, Hirofumi
发表日期：2024
文献求助 收藏

Parallel administration of nanoliposomal irinotecan and levo-leucovorin for pancreatic cancer

纳米脂质体伊立替康与左亚叶酸钙平行给药治疗胰腺癌

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-023-11205-6
Takada, Ryoji; Ikezawa, Kenji; Yamai, Takuo; Watsuji, Ko; Seiki, Yusuke; Kawamoto, Yasuharu; Hirao, Takeru; Higashi, Sena; Urabe, Makiko; Kai, Yugo; Nakabori, Tasuku; Uehara, Hiroyuki; Kotani, Michiyo; Yagi, Toshinari; Kimura, Miho; Nozaki, Keisuke; Takagi, Mari; Ohkawa, Kazuyoshi
胰腺癌
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏